Literature DB >> 11815737

Maternal antigen stimulation downregulates via mother's milk the specific immune responses in young mice.

E Bednar-Tantscher1, G C Mudde, A Rot.   

Abstract

BACKGROUND: Different aspects of the vertical transfer of predisposition to allergy from mother to child have been investigated. An issue which is still largely open is the influence of breast-feeding by allergic mothers on the development of the allergic phenotype of the infant. In the current study we employed a murine ovalbumin (OVA) immunization model to investigate possible milk-borne influences of the mother's specific immune status on the primary immune response of the breast-fed pup.
METHODS: Naïve and OVA-immunized female mice were mated simultaneously. Immediately after birth litters were exchanged between the immunized and the untreated mothers which allowed the evaluation of maternal influence exerted via milk only. At the age of 3 weeks the pups were injected with a single dose of OVA intraperitoneally and sacrificed 2 weeks later. Serum was obtained for the determination of total and OVA-specific IgE and IgG2a. In addition, lymphocyte proliferation was measured following OVA stimulation of the pups' splenocytes and lymph node cells. During the lactation period milk was collected from the mothers for evaluation of its total and OVA-specific immunoglobulin levels.
RESULTS: Breast-feeding of naïve pups by OVA-immunized mothers results in the suppression of the pups' specific IgE response as well as the downregulation of the OVA-induced proliferative response of the pups' lymph node cells and splenocytes. Additionally, splenocytes of naïve pups nursed by immune mothers show a decrease in IL-4 production compared to naïve pups nursed by naïve mothers, whereas the IFN-gamma production is not altered.
CONCLUSION: We demonstrated the suppression of the pups' primary humoral and cellular response towards OVA by breast-feeding by mothers exposed to OVA shortly before pregnancy. It appears that such a transfer of the suppressive activity from mother to pups via milk directs the pups' immune response towards a Th1 and away from a Th2 type, thus avoiding the 'allergic' phenotype. Our study suggests that breast-feeding by mothers immune to an antigen may suppress the development of an allergic response to this antigen. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11815737     DOI: 10.1159/000049527

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  5 in total

1.  What dogs may teach humans about the vertical transmission of allergy predisposition.

Authors:  Barbara Zemann; Antal Rot
Journal:  Immunology       Date:  2003-12       Impact factor: 7.397

2.  Maternal peanut consumption provides protection in offspring against peanut sensitization that is further enhanced when co-administered with bacterial mucosal adjuvant.

Authors:  Iván López-Expósito; Kirsi M Järvinen; Alexandra Castillo; Antti E Seppo; Ying Song; Xiu-Min Li
Journal:  Food Res Int       Date:  2011-07       Impact factor: 6.475

3.  Maternal transmission of resistance to development of allergic airway disease.

Authors:  Adam P Matson; Li Zhu; Elizabeth G Lingenheld; Craig M Schramm; Robert B Clark; Dawn M Selander; Roger S Thrall; Elena Breen; Lynn Puddington
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

4.  Anti-ulcer treatment during pregnancy induces food allergy in mouse mothers and a Th2-bias in their offspring.

Authors:  Isabella Schöll; Ute Ackermann; Cevdet Ozdemir; Nicole Blümer; Tanja Dicke; Serdar Sel; Sarper Sel; Michael Wegmann; Krisztina Szalai; Regina Knittelfelder; Eva Untersmayr; Otto Scheiner; Holger Garn; Erika Jensen-Jarolim; Harald Renz
Journal:  FASEB J       Date:  2007-01-16       Impact factor: 5.191

5.  Transmission of allergen-specific IgG and IgE from maternal blood into breast milk visualized with microarray technology.

Authors:  Heidrun Hochwallner; Johan Alm; Christian Lupinek; Catharina Johansson; Axel Mie; Annika Scheynius; Rudolf Valenta
Journal:  J Allergy Clin Immunol       Date:  2014-11-05       Impact factor: 10.793

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.